Immunoassays for the development and validation of Bioalloy Detection Prototypes


  1. Ruttan, C.
  2. Dickinson-Laing, T.
  3. Man, D.C.W.
Corporate Authors
Defence R&D Canada - Suffield, Ralston ALTA (CAN);Canada West Biosciences, Calgary ALTA (CAN)
With the current concerns over potential biowarfare incidents, attention has turned to improving technologies for the rapid detection and identification of biowarfare agents. These agents include viruses, protists, bacteria, fungi, parasites and toxins and may be classified into three levels. Category A agents have high rates of transmission and/or fatalities. Category B agents can spread with moderate ease and cause moderate rates of disease with low death rates. Category C agents could be modified for dissemination due to availability or easy production and spreading thus potentially leading to high infection and/or death rates. Due to the variety of agents of interest, a single approach for detection and identification is not feasible. This report provides an overview of detection platforms that are currently available or being investigated for pathogen detection. Although the original objective of this contract was to provide DRDC Suffield with an independent analysis of the breadboards and prototypes delivered by IatroQuest Corporation through the development of applicable comprehensive immunoassays such could not be completed without the delivery of the necessary hardware. Therefore it is through this review of present detection and identification platforms that an understanding of the objectives of the work is shown.
Report Number
DRDC-SUFFIELD-CR-2009-155 — Contractor Report
Date of publication
01 Mar 2009
Number of Pages
Electronic Document(PDF)

Permanent link

Document 1 of 1

Date modified: